Intermediate cell adhesion: role of calreticulin and LRP
Intermediate cell adhesion: role of calreticulin and LRP
批准号:
6868316
负责人:
JOANNE E MURPHY-ULLRICH
金额:
$36.17万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-16 至 2008-11-30
关键词:
angiogenesisapoptosisbinding sitesbiological signal transductioncalreticulincell adhesioncell growth regulationendocytosisenzyme linked immunosorbent assayflow cytometryheparinhuman tissueimmunoprecipitationinterference microscopylaboratory mouselow density lipoprotein receptorphosphorylationprotein bindingprotein purificationprotein structure functionregenerationthrombospondinstissue /cell culturewound healing
中文摘要
描述(由申请人提供):细胞功能由细胞骨架的化学和机械信号调节。中间细胞粘附是由血栓反应蛋白(TSP)诱导的状态,在这种状态下,局灶性粘附被分解,但细胞仍然扩散和整合素聚集。TSP活性位点是肝素结合域(HBD)中的一个19aa序列(hep I肽),通过细胞表面钙调蛋白(CRT)和低密度脂蛋白受体相关蛋白(LRP)的受体共复合体发出信号。Hep I信号表明局灶黏附破坏,刺激细胞运动和侵袭,抗凋亡信号的产生,以及内皮细胞管的形成。因此,我们认为I型肝炎病毒的中间粘附状态信号是对细胞应激的适应性反应,这在组织重塑、修复和发育中很重要。本课题的主要目的是通过对体内组织修复中TSP/hep信号的研究,确定通过CRT-LRP复合物介导的TSP信号的分子机制以及中间粘附状态的生理意义。在Specific Aim 1中,将通过识别CRT中的LRP结合位点,并通过在生物试验中使用表达缺乏hep I或LRP结合位点的CRT的转基因细胞来研究TSP-CRT-LRP信号复合物的分子基础。在Specific Aim 2中,将通过研究tsp依赖性G蛋白/适配器蛋白结合、自磷酸化、脂筏定位以及lrp介导的CRT内吞和局灶黏附调节来研究CRT- lrp信号传导。TSP信号对中间粘附的生理意义将在Specific Aim 3中讨论。我们将进一步研究TSP/HBD/hep I信号对细胞侵袭和促进粘附依赖性存活的影响。在体内海绵肉芽肿模型中,传递表达hep I或HBD的质粒,为入侵细胞提供局部、持续的转染,将用于确定该信号在组织修复过程中细胞入侵、凋亡和血管生成中的作用。这些研究将首次从生物学角度了解中间粘连在组织重塑中的作用,并对伤口修复、慢性损伤疾病(动脉粥样硬化)、转移和组织工程具有指导意义。
英文摘要
DESCRIPTION (provided by applicant): Cell function is regulated by chemical and mechanical signaling from the cytoskeleton. Intermediate cell adhesion is the state induced by thrombospondins (TSP), in which focal adhesions are disassembled, but cells remain spread and integrin clustered. The TSP active site is a 19 aa sequence (hep I peptide) in the heparin-binding domain (HBD) which signals through the receptor co-complex of cell surface calreticulin (CRT) and LDL receptor-related protein (LRP). Hep I signals focal adhesion disassembly, stimulation of cell motility and invasion, generation of anti-apoptotic signals with rescue from anoikis, and endothelial cell tube formation. Thus, we propose that hep I signaling of the intermediate adhesive state is an adaptive response to cellular stress which is important in tissue remodeling, repair, and development. The major goals of this proposal are to determine the molecular mechanisms of TSP signaling through CRT-LRP complexes and the physiological significance of the intermediate adhesive state through study of TSP/hep I signaling in tissue repair in vivo. In Specific Aim 1, the molecular basis of the TSP-CRT-LRP signaling complex will be studied by identifying the LRP binding site in CRT and through use of transgenic cells expressing CRT lacking the hep I or LRP binding sites in biological assays. In Specific Aim 2, CRT-LRP signaling will be studied by investigation of TSP-dependent G protein/adapter protein binding, autophosphorylation, localization to lipid rafts, and study of LRP-mediated CRT endocytosis and focal adhesion regulation. The physiological significance of TSP signaling of intermediate adhesion will be addressed in Specific Aim 3. TSP/HBD/hep I signaling of cell invasion and promotion of adhesion-dependent survival will be studied further. An in vivo sponge granuloma model which delivers plasmid expressing hep I or the HBD to provide local, sustained transfection of invading cells will be used to determine the role of this signaling in cell invasion, apoptosis, and angiogenesis during tissue repair. These studies will provide the first biologic insights into the role of intermediate adhesion in tissue remodeling, with implications for wound repair, diseases of chronic injury (atherosclerosis), metastasis, and tissue engineering.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The thrombospondin1-TGF-beta axis in multiple myeloma
-
批准号:8761464
-
项目类别:
-
资助金额:$60.82万
-
财政年份:2014
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
The thrombospondin1-TGF-beta axis in multiple myeloma
-
批准号:8893914
-
项目类别:
-
资助金额:$59.83万
-
财政年份:2014
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
The thrombospondin1-TGF-beta axis in multiple myeloma
-
批准号:9324935
-
项目类别:
-
资助金额:$59.83万
-
财政年份:2014
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
The thrombospondin1-TGF-beta axis in multiple myeloma
-
批准号:9111835
-
项目类别:
-
资助金额:$59.83万
-
财政年份:2014
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
FASEB SRC on Matricellular Proteins in Development, Health, and Disease
-
批准号:8597731
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2013
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Thrombospondins and other matricellular proteins in tissue organization and homeo
-
批准号:8004379
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2010
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Fibroblast control of TGF-beta activation by Thy-1 and lung fibrosis
-
批准号:7341144
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2007
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Fibroblast control of TGF-beta activation by Thy-1 and lung fibrosis
-
批准号:7176258
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2007
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Thrombospondin1 antagonists and diabetic nephropathy
-
批准号:7590423
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2007
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Thrombospondin1 antagonists and diabetic nephropathy
-
批准号:8055561
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2007
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Thrombospondin1 antagonists and diabetic nephropathy
-
批准号:7244734
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2007
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
CORE--TISSUE CHARACTERIZATION AND IMMUNOREAGENT RESOURCE
-
批准号:7069764
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2005
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Intermediate cell adhesion: role of calreticulin and LRP
-
批准号:6998481
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2004
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Intermediate cell adhesion: role of calreticulin and LRP
-
批准号:7149159
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2004
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Intermediate cell adhesion: role of calreticulin and LRP
-
批准号:7324107
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2004
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis
-
批准号:6700262
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2002
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis
-
批准号:6620172
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2002
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis
-
批准号:6851797
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2002
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis
-
批准号:6419901
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2002
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
THROMBOSPONDIN IN GLUCOSE-MEDIATED TGFB UPREGULATION
-
批准号:6178133
-
项目类别:
-
资助金额:$22.66万
-
财政年份:1998
-
负责人:JOANNE E MURPHY-ULLRICH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: